Skip to main content
Emily Zeitler, MD, Cardiology, Lebanon, NH

EmilyPZeitlerMD

Cardiology Lebanon, NH

Cardiac Electrophysiology

Cardiology Fellow

Dr. Zeitler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Zeitler's full profile

Already have an account?

  • Office

    Dartmouth-Hitchcock Medical Center
    One Medical Center Drive
    Lebanon, NH 03756
    Phone+1 603-650-4590
    Fax+1 603-650-0523

Summary

  • Dr. Emily Zeitler is an electrophysiologist in Lebanon, NH and is affiliated with the Dartmouth-Hitchcock Medical Center. She received her medical degree from Emory University School of Medicine. She completed residency in internal medicine at Massachusetts General Hospital and fellowships in Cardiology, Clinical Research, and Electrophysiology at Duke University. She started practicing electrophysiology in 2018.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Cardiovascular Disease, 2012 - 2016
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2008 - 2011
  • Emory University School of Medicine
    Emory University School of MedicineClass of 2008

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 2018 - 2026
  • VT State Medical License
    VT State Medical License Active through 2024
  • NC State Medical License
    NC State Medical License 2011 - 2018
  • MA State Medical License
    MA State Medical License 2010 - 2011
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Clinical Cardiac Electrophysiology

Publications & Presentations

PubMed

Abstracts/Posters

  • [Board 169] Coverage With Evidence Development: Where Are We Now?
    Emily Zeitler, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/16/2019

Lectures

  • Case #3 Medication Use in Long QT Syndrome 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Recalled ICD Generators in the NCDR-ICD Registry: Outcomes and Surveillance Implications 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Case 3 Debate: CHB After TAVR in Patient With EF < 35% - Minimal Device Therapy for Best Outcome 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Authored Content

  • Reply the Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of ComorbiditiesOctober 2017

Press Mentions

  • Study Finds Catheter Ablation Significantly Lowers Risk of Dementia in Patients with Atrial Fibrillation
    Study Finds Catheter Ablation Significantly Lowers Risk of Dementia in Patients with Atrial FibrillationNovember 10th, 2022
  • Coverage with Evidence Development: Where Are We Now?
    Coverage with Evidence Development: Where Are We Now?August 1st, 2022
  • Cardiac Resynchronization Therapy Boosts Care for Older HFrEF Patients
    Cardiac Resynchronization Therapy Boosts Care for Older HFrEF PatientsJanuary 17th, 2022
  • Join now to see all